產(chǎn)品搜索
相關(guān)文章
- 腫瘤細(xì)胞到底是如何“轉(zhuǎn)移”的呢?
- TIGIT&PVRIG雙靶點(diǎn)細(xì)胞篩選模型
- 羅氏免疫療法獲FDA批準(zhǔn)治療晚期非小細(xì)胞肺癌(NSCLC)
- 官宣!Ba/F3激酶穩(wěn)定細(xì)胞株&科佰激酶篩選平臺(tái)
- 【新品上線】AXL篩選模型
- ATCC細(xì)胞株培養(yǎng)操作
- 科學(xué)家發(fā)現(xiàn)10個(gè)新的智力障礙易感基因
- 潛力十足的T細(xì)胞療法,我們用得起嗎?
- PD-1/PD-L1:研發(fā)過(guò)剩還是大有可為
- 腫瘤細(xì)胞調(diào)控關(guān)鍵因子和機(jī)制的研究講解
聯(lián)系我們
電話:4008750250
號(hào)碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號(hào)
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73283c-Kit W557_K558del-V654A/BaF3

- 詳細(xì)內(nèi)容
CBP73283 | |
I. Introduction | |
Cell Line Name: | c-Kit W557_K558del-V654A/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Application: | Anti-proliferation assay and PD assay |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
KIT W557_K558del results in the deletion of 2 amino acids in the juxtamembrane domain (exon 11) of the Kit protein from amino acids 557 to 558 (PMID: 12918066). W557_K558del results in constitutive activation of Kit and increased Erk phosphorylation, and leads to increased invasiveness and expression of ETV1 in cell culture (PMID: 25239608, PMID: 26936919). | |
III. Representative Data | |
1.WB of c-Kit W557_K558del-V654A/BaF3 | |
2.Sanger of c-Kit W557_K558del-V654A/BaF3 Figure 2. c-Kit W557_K558del-V654A/BaF3 V654A Figure 3. c-Kit W557_K558del-V654A/BaF3 W557_K558del | |
3. Anti-proliferation assay Figure 4. CTG Proliferation Assay of BaF3 C-KIT W557_ K558del/V654A(C8). | |
|